Epidemiological evidence indicates a link between obesity and human colon cancer. A putative association between obesity and colon tumorigenesis has been explored experimentally using chemical carcinogens administered to obese rodents. The main objective of this study was to generate a new mouse line that displays both obesity and intestinal tumorigenesis. To this end, we have generated C57BLKS-mLepr db/db ; Apc 1638N/ þ mice combining both db and Apc mutations. The db mutation results in obesity and type 2 diabetes, the Apc mutation is a key initiating event of intestinal neoplasia. All mice were euthanized at 6 months of age and all regions of the gastrointestinal tract examined for tumors. The results show that the combination of Apc 1638N/ þ and db mutations not only enhanced mutant Apc-driven small intestinal tumorigenesis but also induced gastric and colonic tumors. Homozygous db mice did not develop gastrointestinal neoplasia. These findings indicate that obesity associated with type 2 diabetes promotes gastrointestinal tumorigenesis in Apc-deficient mice and provides evidence of a mechanistic link between obesity and colorectal neoplasia.
Obesity, a major public health concern in many developed countries, has become a focus of intense investigation to identify diet and lifestyle factors associated with an increased risk of cancer. 1 Epidemiological studies indicate a link between obesity and colon carcinogenesis. [1] [2] [3] A putative association between obesity and colon cancer has been explored experimentally using chemical carcinogens administered to obese rodents. 4, 5 The main objective of this study was to generate a new mouse line that displays both obesity and intestinal tumorigenesis. To this end, we have generated double mutant C57BLKS-mLepr db/db ; Apc 1638N/ þ mice, henceforth referred to as Lepr db/db ; Apc 1638N/ þ ; Lepr db/db mice carry a missense mutation resulting in premature termination of the intracellular domain of the long form of the leptin receptor (Ob-Rb, ref. Following euthanasia, the gastrointestinal tract was removed and divided into six segments: (i) stomach, (ii) duodenum, (iii) jejunum, (iv) ileum, (v) cecum and (vi) colon. Each segment was gently infused with cold PBS and immediately inflated with 10% neutral-buffered formalin. These segments were then loosely rolled in concentric circles, placed in tissue cassettes, immersion-fixed in formalin and routinely processed. Paraffin sections (5 mm)
were stained with hematoxylin and eosin. Preneoplastic and neoplastic lesions were diagnosed according to recommendations detailed in Boivin GP et al.
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Data are expressed as mean values±s.e.m. or ±s.d. Student's t-test (independent two population t performed with Origin 6.0) was applied to determine statistically significant differences between two mean values. P-value o0.001 was considered significantly different.
The main findings of this study were (i) homozygous ; Apc 1638N/ þ mice (n ¼ 19): stomach (1-2, 1.25 ± 0.25), duodenum (0-8, 2.5 ± 1.96), jejunum (0-10, 3.9 ± 2.6), ileum (0-5, 2.7 ± 1.37), cecum (0-1) and colon (0-2, 1.5 ± 0.22).
Obesity and gastrointestinal tumorigenesis C Gravaghi et al consequence of the pre-existing genetic lesion. 8, 9 No intestinal tumors were found in wild-type littermates (data not shown). The mean number of gastrointestinal tumors, scored in Lepr db/db ; Apc 1638N/ þ mice, was markedly higher compared with Apc 1638N/ þ mice (5.9 ± 0.87 vs 1.5 ± 0.34, Po0.001, Figure 1a ). All tumors were adenomas. Of particular interest was the formation of gastric and colonic tumors (Figure 1c ), 21 and 32% respectively, in double mutant mice at 6 months of age because these tumors did not develop in single mutant Apc 1638N/ þ mice ( Figure 1b) and are infrequently observed in older Apc 1638N/ þ mice. 9 A representative sample of gastric and colonic adenomas both found in a Lepr db/db ; Apc 1638N/ þ mouse is shown in Figure 2 . The present findings indicate that the hormonal and metabolic background of the db/db mouse modulates gastrointestinal neoplasia in the presence of a pre-existing Apc mutation.
The factors contributing to the complex phenotype of obesity and diabetes mellitus in homozygous db mice include insulin resistance, dyslipidemia and hyperglycemia all of which have been independently implicated in having possible effects on colon cancer progression. [1] [2] [3] Hyperleptinemia is an additional metabolic feature of db/db mice. A number of studies have shown that leptin exerts in vitro a marked growth-promoting action on small intestinal and colon cancer cells. 12 Interestingly, a recent study using microarray analysis showed that leptin upregulated growth-related genes in Apc-mutant colonic cells, but was ineffective in Apc þ / þ normal colonic cells. 13 Hirose et al. 14 reported that administration of the colonic procarcinogen azoxymethane to db/db mice resulted in enhanced induction of colonic preneoplastic aberrant crypt foci, and suggested that hyperleptinemia may be a causative factor in this process. In contrast, Ealey et al. 15 recently
reported that there were no differences in aberrant crypt foci number or multiplicity between db/db and leptin-deficient ob/ob mice treated with azoxymethane. The undefined link between human obesity, hyperleptinemia and colon neoplasia, suggested in nested case-control studies, 16 has been recently reviewed. 17 Obesity is associated with chronic inflammation 2 and an increase in pro-inflammatory cytokines such as leptin. 18 One may posit that sustained obesity-induced inflammation contributes to cellular and molecular events promoting gastrointestinal tumorigenesis in Lepr db/db ; Apc 1638N/ þ mice.
This is an attractive possibility that warrants further investigation, considering that a mechanistic link between inflammation and colon cancer has been proposed. 
Obesity and gastrointestinal tumorigenesis C Gravaghi et al
Growing attention is focused on a possible link between altered energy balance and cancer. 20 Excess calories intake associated with a marked increase in metabolic efficiency are hallmarks of obese homozygous db/db mice. 21 The question therefore arises whether these factors had a contributory role in fostering intestinal carcinogenesis in Lepr db/db ; Apc 1638N/ þ mice. It is relevant to note here that dietary calorie restriction in Apc Min mice resulted in a marked reduction in serum leptin levels and in small intestinal tumor burden, 22, 23 indicating that the energy balance plays a role in modulating intestinal neoplasia. Patel et al. 23 have incisively reviewed the effects of changes in energy balance and calorie intake on the process of tumorigenesis. It is increasingly evident that environmental factors, including modified lifestyle such as diet, can modulate the severity of the obese genotype. 24 The observation that dietary energy balance modulates key signaling pathways downstream cell-surface receptors 25 provides a versatile blueprint for combinatory interventions (for example, changes in calories intake and chemopreventive/pharmacological treatments) to modify the obese phenotype and, in turn, to interfere with obesity-driven neoplasia in humans.
The mouse model generated in the present study, combining both obesity and intestinal tumorigenesis, may represent a testable preclinical system for validation of this approach.
In conclusion, we have shown that obesity associated with diabetes mellitus markedly modulates gastrointestinal tumorigenesis in Apc-mutant mice and have provided evidence of a mechanistic link between obesity and intestinal neoplasia.
